Stephen J Fiascone, MD

Assistant Professor, Periodontology

617.414.5175
fiascone@bu.edu
771 Albany Street
View full profile at BUMC

Biography

Dr. Stephen Fiascone, MD is an obstetrician-gynecologist in Boston, Massachusetts and is affiliated with Brigham and Women’s Hospital. He received his medical degree from Harvard Medical School and has been in practice between 3-5 years.

Websites

Education

  • Harvard Medical School, MD
  • Harvard College, AB

Publications

  • Published on 9/28/2023

    Matthews BJ, Fiascone SJ. Evidence for some, extrapolation for others: Levonorgestrel IUDs and health equity in Gynecologic Oncology. Gynecol Oncol Rep. 2023 Oct; 49:101285. PMID: 37868624.

    Read at: PubMed
  • Published on 2/16/2023

    Kajtezovic S, Morgan JR, Fiascone S, Brandt HM, Perkins RB. Optimizing timing of adolescent vaccines: Impact of initiating HPV vaccination before Tdap or meningococcal vaccination on timely completion of the HPV vaccine series. Hum Vaccin Immunother. 2023 Dec 31; 19(1):2175541. PMID: 36798049.

    Read at: PubMed
  • Published on 9/21/2022

    Lee YW, Morgan JR, Fiascone S, Perkins RB. Underscreening, overscreening, and guideline-adherent cervical cancer screening in a national cohort. Gynecol Oncol. 2022 Nov; 167(2):181-188. PMID: 36150914.

    Read at: PubMed
  • Published on 4/21/2022

    Gockley A, Pagacz K, Fiascone S, Stawiski K, Holub N, Hasselblatt K, Cramer DW, Fendler W, Chowdhury D, Elias KM. A Translational Model to Improve Early Detection of Epithelial Ovarian Cancers. Front Oncol. 2022; 12:786154. PMID: 35530324.

    Read at: PubMed
  • Published on 11/14/2021

    Matthews BJ, Qureshi MM, Fiascone SJ, Nitschmann CC, Oladeru OT, Truong MT, Hirsch AE, Mak KS, Dyer MA. Racial disparities in non-recommendation of adjuvant chemotherapy in stage II-III ovarian cancer. Gynecol Oncol. 2022 01; 164(1):27-33. PMID: 34785030.

    Read at: PubMed
  • Published on 10/29/2021

    Brummelhuis IS, Fiascone SJ, Hasselblatt KT, Frendl G, Elias KM. Voltage-Gated Sodium Channels as Potential Biomarkers and Therapeutic Targets for Epithelial Ovarian Cancer. Cancers (Basel). 2021 Oct 29; 13(21). PMID: 34771603.

    Read at: PubMed
  • Published on 3/12/2019

    Cheung TH, Yim SF, Yu MY, Worley MJ, Fiascone SJ, Chiu RWK, Lo KWK, Siu NSS, Wong MCS, Yeung ACM, Wong RRY, Chen ZG, Elias KM, Chung TKH, Berkowitz RS, Wong YF, Chan PKS. Liquid biopsy of HPV DNA in cervical cancer. J Clin Virol. 2019 05; 114:32-36. PMID: 30913520.

    Read at: PubMed
  • Published on 3/1/2019

    Gockley AA, Fiascone S, Hicks Courant K, Pepin K, Del Carmen M, Clark RM, Goldberg J, Horowitz N, Berkowitz R, Worley M. Clinical characteristics and outcomes after bowel surgery and ostomy formation at the time of debulking surgery for advanced-stage epithelial ovarian carcinoma. Int J Gynecol Cancer. 2019 03; 29(3):585-592. PMID: 30833444.

    Read at: PubMed
  • Published on 2/7/2019

    Alimena S, Fiascone S, Krasner C, King M, Horowitz N. A tumor board report of an 83-year-old woman with stage IB grade 3 endometrioid endometrial adenocarcinoma. Curr Probl Cancer. 2019 10; 43(5):443-449. PMID: 30770127.

    Read at: PubMed
  • Published on 10/30/2018

    Hill EK, Stuckey A, Fiascone S, Raker C, Clark MA, Brown A, Gordinier M, Robison K. Gender and the Balance of Parenting and Professional Life among Gynecology Subspecialists. J Minim Invasive Gynecol. 2019 Sep - Oct; 26(6):1088-1094. PMID: 30389582.

    Read at: PubMed

View 8 more publications: View full profile at BUMC

View all profiles